[{"uuid": "59b2df6b-5c06-314a-b552-8be524f7e948", "title": "Akoya Biosciences Selects Argonaut Manufacturing Services as IVD Manufacturing Partner", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/akoya-biosciences-selects-argonaut-manufacturing-110000858.html", "providerPublishTime": 1738062000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/kuz8_ad1wj3_TvLV81.3hw--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/7b005a1f4d768157eb7a7bfc511d2062", "width": 1024, "height": 512, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/9Wbn95_lpCJLd1pCGB1aFg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/7b005a1f4d768157eb7a7bfc511d2062", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "43bce6f1-6df0-343e-b01f-d1de3218e477", "title": "Canaccord Genuity Downgrades Akoya Biosciences to Hold From Buy, $3.50 Price Target", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/canaccord-genuity-downgrades-akoya-biosciences-122513253.html", "providerPublishTime": 1736771113, "type": "STORY", "relatedTickers": ["AKYA"]}, {"uuid": "068e8ac0-e6bf-3b80-b10d-e09302f36941", "title": "Top Premarket Decliners", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/top-premarket-decliners-132921065.html", "providerPublishTime": 1736774961, "type": "STORY", "relatedTickers": ["VMAR"]}, {"uuid": "2507eb80-2f4f-38c9-a9ee-e615e14dff3a", "title": "Quanterix Agrees to Acquire Akoya Biosciences in All-Stock Deal", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/quanterix-agrees-acquire-akoya-biosciences-124928754.html", "providerPublishTime": 1736513368, "type": "STORY", "relatedTickers": ["QTRX", "AKYA"]}, {"uuid": "c54586d4-436f-3edb-a2a3-76f6ea2cad93", "title": "Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/quanterix-acquire-akoya-biosciences-creating-120000428.html", "providerPublishTime": 1736510400, "type": "STORY", "relatedTickers": ["AKYA", "QTRX"]}, {"uuid": "8b892dbe-1096-309c-b080-5d11f647550c", "title": "Traders Digest Strong Jobs Growth as US Equity Futures Drop Pre-Bell", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/traders-digest-strong-jobs-growth-135509413.html", "providerPublishTime": 1736517309, "type": "STORY", "relatedTickers": ["^GDAXI", "^FTSE"]}, {"uuid": "963aaa10-916e-3f42-ac9e-4905a3a0cdaf", "title": "Top Premarket Gainers", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/top-premarket-gainers-125042568.html", "providerPublishTime": 1736513442, "type": "STORY", "relatedTickers": ["AKYA", "VMAR"]}, {"uuid": "9f54a137-1fed-3e5b-9e0e-eaefeaace2a9", "title": "Akoya Biosciences (AKYA) Reports Q3 Loss, Lags Revenue Estimates", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/akoya-biosciences-akya-reports-q3-221003152.html", "providerPublishTime": 1731622203, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/64vRzkiY9LXGPrpW4r2GRQ--~B/aD00Njc7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b95cfdd8768bc3c4620e666dbcb0b248", "width": 900, "height": 467, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/K_VbSLl5PAgBcdM4TzmL5A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/b95cfdd8768bc3c4620e666dbcb0b248", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AKYA", "BRBR"]}, {"uuid": "62f8ce8f-2b95-38c1-bf82-973476e18397", "title": "Akoya Biosciences Secures Exclusive License for NeraCare's Immunoprint Test", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/akoya-biosciences-secures-exclusive-license-140310861.html", "providerPublishTime": 1733839390, "type": "STORY", "relatedTickers": ["AKYA"]}, {"uuid": "cad165bc-ff18-3407-a149-267f0272d550", "title": "Time To Worry? Analysts Just Downgraded Their Akoya Biosciences, Inc. (NASDAQ:AKYA) Outlook", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/time-worry-analysts-just-downgraded-131121082.html", "providerPublishTime": 1731849081, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/dC75hPkPk1wNzUHQ29Af1A--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/6yvSv34WjsBU70VeapBSyg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AKYA"]}, {"uuid": "7e792c18-81ef-35d5-a518-fb7fec4b3f96", "title": "Nature Methods Names Spatial Proteomics \"Method of the Year 2024\" \u2014 Akoya Biosciences Celebrates Industry Milestone", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/nature-methods-names-spatial-proteomics-130000756.html", "providerPublishTime": 1733749200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/HlPHD3iw6dc22v3aSGXhMg--~B/aD0zNzA7dz0xNDg5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/77d0f2caf972d5d9c3d584df2954d077", "width": 1489, "height": 370, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/c53RT8KeO8kOSNzKXGVudw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/77d0f2caf972d5d9c3d584df2954d077", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AKYA"]}, {"uuid": "ee973070-90a8-3a3f-bd35-b7bf58bad1d5", "title": "Akoya Biosciences Reports Third Quarter 2024 Financial Results", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/akoya-biosciences-reports-third-quarter-210000083.html", "providerPublishTime": 1731618000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/HlPHD3iw6dc22v3aSGXhMg--~B/aD0zNzA7dz0xNDg5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/77d0f2caf972d5d9c3d584df2954d077", "width": 1489, "height": 370, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/c53RT8KeO8kOSNzKXGVudw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/77d0f2caf972d5d9c3d584df2954d077", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AKYA"]}]